Long-Acting Injectable (LAI) Antipsychotics in Bipolar Disorder and Schizophrenia

Long-Acting Injectable (LAI) Antipsychotics in Bipolar Disorder and Schizophrenia Oliver Freudenreich, MD, FAPM

Related Episodes

Continue listening to more episodes from MGH Psychiatry Academy Podcasts.

Mar 24, 2016 - 26:10

Overview: Limitations of Current Treatment of Depression Maurizio Fava, MD

Mar 24, 2016 - 53:33

Assessing and Managing Metabolic Risk in Bipolar Disorder and Schizophrenia Dost Ongur, MD, PhD

Mar 24, 2016 - 48:28

Assessment and Treatment of Affective Symptoms in Schizophrenia Oliver Freudenreich, MD, FAPM

Mar 24, 2016 - 19:56

Optimal Treatment of Psychosis in Bipolar Disorder Sharmin Ghaznavi, MD, PhD

Mar 24, 2016 - 45:38

Early Detection and Intervention in Bipolar Disorder and Schizophrenia Andrew A. Nierenberg, MD

Jun 16, 2014 - 35:58

Anxiety and Depression: Pharmacological Approaches Cristina Cusin, MD

Jun 16, 2014 - 46:51

Anxiety in the Setting of Depression: Risk, Comorbidity, and Residual Symptoms Naomi Simon, MD, MSc

Jun 16, 2014 - 44:00

Cognitive Dysfunction in Depressed Patients Andrew Nierenberg, MD